PUK11 COST-MINIMIZATION ANALYSIS: MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA) VS. ARANESP (DARBEPOETIN ALFA) IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) WHO ARE NOT RECEIVING HAEMODIALYSIS, IN POLISH SETTING

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions